Part B: Krystyna Gustelle takes us along her doctoral journey on Medical Pluralism in 19th Century America - and its meaning for today’s challenges. Krystyna had a 35 year career in pharmaceutical industry with Johnson & Johnson, Astra Zeneca, Pfizer and GlaxoSmithKline. She was responsible for global communications for new oncology drugs, managed communication strategies for FDA approval of new medicines for breast cancer, kidney cancer, melanoma and colorectal cancer, and is a past President and current Chair Emeritus of Healthcare Business Women Association (HBA).